Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 30, 2016
Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B
K Kavakli, L Smith, K Kuliczkowski, et al.
Leukemia & Lymphoma
|
September 14, 2004
Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre study
M Kowal, A Dmoszyńska, K Lewandowski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 13, 2010
Pharmacokinetics of Optivate(®), a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A
A Dmoszynska, A Hellmann, T Baglin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 5, 2011
Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A
A Dmoszynska, K Kuliczkowski, A Hellmann, et al.
Neoplasma
|
February 14, 2003
The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study
A Wrzesien-Kus, T Robak, K Jamroziak, et al.
European Journal of Haematology
|
August 22, 2003
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)
A Wrzesień-Kuś, T Robak, E Lech-Marańda, et al.
Annals of Hematology
|
December 3, 2003
Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience
T Robak, A Szmigielska-Kapłon, A Wrzesień-Kuś, et al.
Annals of Hematology
|
April 28, 2005
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group
A Wrzesień-Kuś, T Robak, A Wierzbowska, et al.
Annals of Hematology
|
March 9, 2006
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG)
A Wrzesień-Kuś, T Robak, A Pluta, et al.
Leukemia
|
October 6, 2001
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia
T Robak, J Z Błoński, M Kasznicki, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 30, 2016
Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B
K Kavakli, L Smith, K Kuliczkowski, et al.
Leukemia & Lymphoma
|
September 14, 2004
Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre study
M Kowal, A Dmoszyńska, K Lewandowski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 13, 2010
Pharmacokinetics of Optivate(®), a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A
A Dmoszynska, A Hellmann, T Baglin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 5, 2011
Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A
A Dmoszynska, K Kuliczkowski, A Hellmann, et al.
Neoplasma
|
February 14, 2003
The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study
A Wrzesien-Kus, T Robak, K Jamroziak, et al.
European Journal of Haematology
|
August 22, 2003
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)
A Wrzesień-Kuś, T Robak, E Lech-Marańda, et al.
Annals of Hematology
|
December 3, 2003
Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience
T Robak, A Szmigielska-Kapłon, A Wrzesień-Kuś, et al.
Annals of Hematology
|
April 28, 2005
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group
A Wrzesień-Kuś, T Robak, A Wierzbowska, et al.
Annals of Hematology
|
March 9, 2006
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG)
A Wrzesień-Kuś, T Robak, A Pluta, et al.
Leukemia
|
October 6, 2001
Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia
T Robak, J Z Błoński, M Kasznicki, et al.
Page
of 10